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Catalytic Mechanism of Mevalonate Kinase Revisited, a QM/MM 
Study  
James McClory,a Jun-Tang Lin,b David Timson, c Jian Zhang d and Meilan Huang*a
Mevalonate Kinase (MVK) catalyses the ATP-Mg2+ mediated phosphate transfer of mevalonate to produce mevalonate 5-
phosphate and is a key kinase in the mevalonate pathway in the biosynthesis of isopentenyl diphosphate, the precursor of 
isoprenoid-based biofuels. However, the crystal structure in complex with the native substrate mevalonate, ATP and Mg2+ 
has not been resolved, which has limited the understanding of its reaction mechanism and therefore its application in the 
production of isoprenoid-based biofuels. Here using molecular docking, molecular dynamic (MD) simulations and a hybrid 
QM/MM study, we revisited the location of Mg2+ resolved in the crystal structure of MVK and determined a catalytically 
competent MVK structure in complex with the native substrate mevalonate and ATP. 
We demonstrated that significant conformational change on a flexilble loop connecting the α6 and α7 helix is induced by 
the substrate binding. Further, we found that Asp204 is coordinated to the Mg2+ ion. Arg241 plays a crucial role in organizing 
the triphosphoryl tail of ATP for in-line phosphate transfer and stabilizing the negative charge that accumulates at the β,γ-
bridging oxygen of ATP upon bond cleavage. Remarkably, we revealed that the phosphorylation of mevalonate catalyzed by 
MVK occurs via a direct phosphorylation mechanism, instead of the conventionally postulated catalytic base mechanism. 
The catalytically competent complex structure of MVK as well as the mechanism of reaction will pave the way for the rational 
engineering of MVK to exploit its applications in the production of biofuels.
Keywords:  GHMP kinase; reaction mechanism; biocatalysis; phosphorylation; isoprenoid biosynthesis; QM/MM  
1 Introduction
Mevalonate kinase (MVK; EC 2.7.1.36) is a key kinase in the 
mevalonate (MVA) pathway. It catalyses the Mg2+-ATP 
dependent phosphorylation of mevalonate to mevalonate-5-
phosphate (Figure 1), a crucial step in the mevalonate pathway 
for the production of isopentenyl diphosphate (IPP) and its 
stereoisomer dimethylallyl diphosphate (DMAPP). IPP is used in 
production of isoprenoids, the important precursors to five-
carbon alcohols and as the initial precursors to longer chain 
terpenes, therefore, MVK has become an attractive biocatalyst 
for the production of environmentally benign biofuels1-2. On the 
other hand, mutations of MVK causes decreased prenylation of 
GTPases3 and mevalonate kinase deficiency (MKD) 4-5, which is 
associated with a range of metabolic autoinflammatory 
diseases such as mevalonic aciduria (MA, MIM# 610377) 6 and 
hyper-immunoglobulin D syndrome (HIDS, MIM# 260920) 7-8. 
MKD is a rare, orphan and neglected disease and so far, there is 
no effective treatment for it. Understanding the catalytic 
mechanism of the MVK would be helpful for exploiting the 
potential biotechnological applications and developing possible 
pharmacological interventions for the MKD-associated disease. 
However, lack of complete kinase structure in complex with the 
substrate mevalonate and unambiguous position/ coordination 
of Mg2+ ion has limited the understanding of the 
phosphorylation mechanism and broader biotechnological 
applications of the kinase.
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Fig. 1 Phosphorylation of mevalonate to mevalonate-5-
phosphate catalysed by MVK.
MVK belongs to GHMP superfamily, which is named after the 
four originally identified members, Galactokinase (GALK; EC 
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2.7.1.6), Homoserine kinase (HSK; EC 2.7.1.39), MVK and 
Phosphomevalonate kinase (PMK; EC 2.7.4.2)9 and has since 
been expanded to include additional members such as N-
acetylgalactosamine kinase (GALK2; EC 2.7.1.157) 10-11, 
galacturonic acid kinase (GalAK; EC 2.7.1.43) 12, arabinose 
kinase (EC 2.7.1.46) 13 and pantoate kinase (EC 2.7.1.169) 14. The 
family is characterised by three highly conserved motifs (I-III). 
Motif I is involved in substrate binding, motif II is a glycine-rich 
loop 138PPGAGLGSSA147 engaged in nucleotide binding and 
motif III is involved in the phosphorylation reaction 9.
Two mechanisms have been proposed for the GHMP kinases. 
The first is the catalytic base mechanism proposed for MVK, 
GALK and MDD whereby phosphate transfer was proposed to 
be preceded by the abstraction of proton from the substrate 
hydroxyl group by a negatively charged residue that functions 
as the catalytic base 15-19. The second plausible mechanism was 
proposed for HSK in which phosphorylation of the substrate 
occurs in the absence of a potential catalytic base thus the 
substrate hydroxyl group directly attacks the γ-phosphate of 
ATP 20. Moreover, even if there is a potential catalytic base in 
the active site, the kinase may not necessarily undergo a base-
assisted phosphorylation. e.g. it was suggested that Asp190 in 
the active site of GALK2 is too far from the substrate to function 
as a catalytic base 21. Recently, QM/MM studies revealed that 
the reactions catalyzed by GALK and PMK occur via direct 
phosphorylation mechanism 22-23. 
Although several different crystal structures of mevalonate 
kinase have been resolved, the position of Mg2+ remains elusive, 
along with the location of its native substrate mevalonate. This 
results in great uncertainty surrounding the reaction 
mechanism of MVK. Here we report a catalytically competent 
structure of the ATP-Mg2+-MVK-MVA complex and reveal the 
reaction mechanism of MVK by using molecular docking, 
molecular dynamic simulations and a combined QM/MM study. 
These findings would provide the basis for the rational 
engineering of MVK for biosynthesis of biofuels and provide 
valuable insights for development of potential therapies for 
MKD-related diseases.
2 Theoretical Methods
2.1 Protein Preparation
The crystal structure of Rattus norvegicus MVK in complex with ATP 
(PDB code: 1KVK) 24 with a resolution of 2.4 Å was used to build the 
complex model of MVK. Magnesium together with three 
coordinating waters was placed beside the γ- phosphate of ATP 
referring to the magnesium coordination in Streptococcus 
pneumoniae PMK, a homologous kinase in GHMP family, for which 
the location of Mg2+ ion has been explicitly resolved 25. The missing 
loop region between residues 73-88 was rebuilt using Modeller v9.17 
26. The protonation states of the titritable residues were decided 
using the H++ webserver27 and by visual inspection (Table S1). 
Asn/Gln/His flips were checked using Reduce encoded in 
AmberTools28.
2.2 Molecular Docking
The mevalonate substrate was docked in the MVK structure 
using AutoDock 4.2 29. Polar hydrogen atoms were added. 
Kollman charges were applied to the protein while RESP charges 
were utilized for the ligand. A grid box was set to cover the 
catalytic residues proposed in previous kinetic studies. The 
Lamarckian genetic algorithm (LGA) was applied with a GA 
population size of 100 and a maximum number of 2,500,000 
energy evaluations. The docked poses were selected for the 
subsequent MD simulations based on the docking score and 
visual inspection of the binding mode.
2.3 Molecular Dynamics Simulations
The AMBER 14 (University of California, USA) package was used 
for Molecular Dynamic Simulations 30. All MD simulations were 
performed with the FF14SB forcefield31. Single point charge 
calculations were run for the substrate and nucleotide using the 
Hartree-Fock (HF) method in conjunction with the 6-31G(d) 
basis set implemented in Gaussian 09 package32 to obtain the 
RESP charges of the ligands (Table S2). The GAFF forcefield33 
was used for the ligands. The ATP-Mg2+-MVK-MVA complex was 
then soaked in a TIP3P water box within a minimum distance of 
10 Å to the boundary of the protein. A total of 11,739 waters 
were added to the complex and Na+ counterions were used to 
maintain the neutrality of the system. 
An initial minimization was performed exclusively for the solute 
involving 1,250 steps of steepest descent minimization followed 
by 1,250 steps of conjugate gradient minimization, where the 
nucleotide, substrate, the magnesium ion and the three 
structural waters were restrained with a force constant of 50 
kcal mol-1A-2. A subsequent minimization was conducted with 
no restraint force applied to the entire protein system.
 The system was then heated slowly from 0 to 300 K for 250 ps 
using the Langevin dynamics with a collision frequency of 1.0 ps-
1. An equilibration simulation was run with a NVT ensemble and 
a periodic boundary condition for a further 50 ps at 300 K. A 
cutoff distance of 8 Å was set for non-bonded Van der Waals 
force while the Particle Mesh Ewald method was used to 
account for the long-range electrostatic interactions. The 
SHAKE method was utilized to fix the covalent bonds associated 
with the hydrogen atoms within the system 34.  A 100-ns 
production simulation with a time step of 1 fs was performed 
for the ATP-Mg2+-MVK-MVA complex utilizing the NPT 
ensemble at 300 K and a pressure of 1 atm. Four replicas of MD 
simulations were run for the wild-type kinase and the variants 
with randomly assigned initial velocities. Root mean square 
deviation (RMSD) of the Cα atoms was calculated (Figure S1) 
using the initially minimized crystal structure as the reference. 
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Cluster analysis was carried out using the AMBER tool CPPTRAJ 
to attain representative structures from the simulation 
trajectory.
2.4 QM/MM Calculations
The representative structures of the ATP-Mg2+-MVK-MVA complex 
were obtained by cluster analysis of the MD simulation trajectory 
and then were used for the subsequent QM/MM study. All QM/MM 
calculations were performed using the ONIOM protocol 
implemented in Gaussian09. The Tao package was used to prepare 
the structures for QM/MM calculation 35. The system was divided 
into two layers, the QM region, which was treated with the b97d 
functional36 accounting for Grimme’s dispersion effect in conjunction 
with a 6-31g(d) basis set and the MM region, which was treated with 
Amber Parm99 force field. An electronic embedding scheme was 
incorporated to integrate the point charge of the MM layer into the 
QM layer37. The quadratically convergent Hartree-Fock (QC-SCF) 
method was used to speed up convergence. The residues within a 
radius of 6 Å of the active site were allowed to move freely while the 
rest residues were kept frozen. 
The QM region contains the divalent metal Mg2+ ion, the side chains 
of Lys13, Ser146, Asp204 and Arg241, the truncated triphosphoryl 
tail of ATP along with the connecting methyl group and a total of 
seven water molecules.  It was composed of a total of 45 heavy atoms 
with a net charge of -2. Charges used for mevalonate and ATP in the 
MD simulations were employed for the QM/MM calculations. 
Representative structures from the MD trajectory were subjected to 
an initial geometry optimization followed by potential energy scan 
(PES) with a decrement of 0.1 Å for the distance between the γ-
phosphorous atom of ATP and the C5-hydroxyl oxygen of 
mevalonate. The transition state (TS) structure attained from the PES 
was optimized as TS and validated using frequency calculation. The 
energies of the stationary points were corrected with the 6-
31++g(d,p) basis set (Table S3).
3 Results and Discussions
3.1 The catalytically competent model of ATP- Mg2+-MVK –MVA
Among the GHMP kinases that are involved in the mevalonate 
pathway, four kinases have their crystal structures be resolved so far, 
namely MVK, MDD, M3K and PMK. However, except for PMK, the 
location of Mg2+ has not been defined in other three kinases. 
Although several crystal structures of MVK have been reported, none 
of these structures were fully resolved with the native substrate 
mevalonate, the nucleotide ATP and the divalent metal Mg2+ ion thus 
leaving ambiguity surrounding the reaction mechanism of MVK. In 
order to obtain the adopted conformation of the substrate MVA in 
presence of Mg2+ and ATP, MVA was docked into the MVK structure 
using Autodock 4.2. An initial catalytically competent conformation 
was chosen based on the docking scores, as well as the feasibility of 
the phosphorylation in view of the reaction coordinates, i.e. the 
distance between the γ-phosphate of ATP and the C5-hydroxyl of 
mevalonate (Figure S2). 
3.1.1 Mg2+ coordination in MVK
In the crystal structure of Rattus norvegicus MVK (PDB Code: 1KVK) 
24, a Mg2+ ion is coordinated with the β- and γ- phosphates of ATP. 
However, it should be noted that the distance between the metal ion 
and phosphate oxygen of ATP is longer than a standard coordinate 
bond, and it is actually analogous to that of a hydrogen bond with a 
water molecule. Glu193 was postulated to be coordinated to the 
Mg2+ ion 18,24. However, the distance between Glu193 and the Mg2+ 
ion (2.8 Å) is also larger than a standard coordinate bond. Therefore, 
in order to elucidate the phosphorylation mechanism of the kinase, 
it is necessary to revisit the location/coordination of Mg2+ to decide 
a catalytically competent complex of MVK.
We first attempted to build a MVK model with Mg2+ coordinated to 
the β- and γ-phosphate oxygen atoms of ATP, which was analogous 
to the suspicious Mg2+ coordination in the crystal structure of Rattus 
norvegicus MVK (PDB Code: 1KVK) 24. However, MD simulations 
revealed that with time evolution, the substrate and ATP moved 
considerably far away from each other, resulting in a non-catalytic 
model of MVK (Figure S3), indicating the crystal structure represents 
a catalytically inactive structure.
In order to determine the catalytically competent configuration of 
MVK complex, a second MVK model was built where a Mg2+ ion was 
placed to be coordinated to the γ-phosphate of ATP, analogous to 
the Mg2+ coordination in S. pneumoniae PMK (PDB Code: 3GON) 25, a 
GHMP kinase homologous to MVK. Further, three coordinating water 
molecules taken from S. pneumoniae PMK were retained to 
coordinate with the Mg2+ in MVK. Further, the Mg2+ ion was 
positioned to be coordinated with the hydroxyl group of the MVA 
substrate, by analogy to PMK, where the metal ion is coordinated to 
the hydroxyl group of the substrate phosphomevalonate (Note the 
coordination was replaced by a fourth coordinating water during the 
subsequent QM/MM optimization). In PMK Mg2+ is coordinated to 
the conserved aspartate Asp29725, which was previously proposed to 
function as a catalytic base 18. Interestingly, in the resulting ATP-
Mg2+-MVK-MVA complex model, the hexa-coordination of Mg2+ ion 
is also saturated by the conserved Asp204. 
The MD simulations showed that the distance between the γ-
phosphate of ATP and the hydroxyl group of MVA is maintained 
between 3.0 Å to 4.0 Å (Figure S4), indicating that the simulated 
structures represent the catalytically competent configurations with 
the mevalonate substrate positioned in a reasonable binding pose in 
relation to ATP in favor of phosphate transfer. Asp204 forms a salt 
bridge interaction with Lys13, which in turn interacts with the γ-
phosphate of ATP (Figure 2 and Figure S5). This is consistent with the 
configuration observed in the crystal structure of Rattus norvegicus 
MVK24. It should be noted that in the crystal structure of Rattus 
norvegicus MVK24, Asp204 is located 3.4 Å away from the postulated 
Mg2+ ion, obviously longer than a standard coordinate bond. 
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However, the coordinate bond between Asp204 and Mg2+ was 
retained in the ATP-Mg2+-MVK-MVA complex throughout the MD 
simulations (Figure S6). 
Remarkably, the MD simulations of the complete ATP-Mg2+-MVK-
MVA complex disclosed that Glu193 is not directly involved in Mg2+ 
coordination, instead, it forms H-bond interactions with two 
coordinating water molecules (WAT441 and WAT461). Thus the 
Hydrogen bonds between Glu193 and the two structural water 
molecules assist in maintaining an ordered octahedral geometry 
centred on the metal ion (Figure S7). Notably, in one of the replicas 
of the MD simulations (Replica 1), Glu193 forms a hydrogen bond 
with His197 on the loop connecting the α6 and α7 helix (Figure 2b 
and S8); the backbone of His197 is in turn engaged in a H-bond 
interaction with Lys244. Thus, His197 may assist to organize the 
active site via the Hydrogen bond with Glu193, rather than help to 
order the nucleotide as previously suggested 24. 
 
Fig. 2 (a) Elusive location of Mg2+ in the crystal structure of 
Rattus norvegicus MVK in absence of mevalonate (pdb code: 
1KVK), (b) Representative MD cluster structure of ATP-Mg2+-
MVK-MVA complex.
3.1.2 Ser201 involved in substrate binding
Kinetic and site-directed mutagenesis studies of the invariant 
serine/threonine residue in over twenty MVK sequences disclosed 
that a S201A mutation in human MVK resulted in a 100-fold increase 
in Km while the turnover rate was relatively unaffected. Thus this 
residue was implicated in substrate binding rather than catalytic 
activity 38. Interestingly, the MD simulations of ATP-Mg2+-MVK-MVA 
complex reveals that as time evolves the hydroxyl side chain of 
Ser201 forms a stable hydrogen bond with the carboxylate group of 
MVA (Figure 2 & S9a). Thus Ser201 is actually involved in substrate 
binding, in accordance with previous kinetic study 38.
3.1.3 The invariant tandem serine residues on P-loop rigidifies ATP
Ser145 and Ser146 are two tandem serine residues highly conserved 
among GHMP kinases (Figure 2). Ser146 was suggested to help to 
orientate ATP, based on large effect on kcat as well as reduced binding 
affinity associated with S146A mutation 38. In the crystal structure of 
R. norvegicus MVK, the hydroxyl side chains of both Ser145 and 
Ser146 form hydrogen bond with the β-phosphate of ATP. With time 
evolution of the MD simulations, Ser146 maintains a hydrogen bond 
with the β-phosphate of ATP (Figure 2 & S9b). Ser145 also maintains 
a hydrogen bond with the β-phosphate of ATP (Figure 2 & S9c). Thus 
the two tandem serine residues Ser145 and Ser146 help to rigidify 
the flexible tail of ATP, facilitating the inline phosphate transfer.
The conserved serine residues Ser145 and Ser146 in MVK are located 
on a glycine-rich loop comprised of the sequence PXXGLXSSA (Figure 
S10), which is the characteristic feature of GHMP kinases39. Actually 
the interactions of these tandem serine residues on the flexible P-
loop with triphosphoryl tail of ATP have been also reported for other 
GHMP kinases, e.g. Thermoplasma acidophilum M3K (Ser107 and 
Ser108), Staphylococcus epidermidis MDD (Ser106 and Ser107) and 
Streptococcus pneumoniae PMK (Ser106 and Ser107). Thus, it is 
evident that these conserved serine residues are crucial in arranging 
the mobile phosphate tail of ATP to facilitate the phosphate transfer 
in GHMP kinases.
3.1.4 Arg241 organizes ATP for in-line phosphate transfer
In the crystal structure of Rattus norvegicus MVK, Arg241 located at 
the loop (238-246) proceeding the α8 helix is away from the active 
site. In the ATP -Mg2+-MVK-MVA complex model, the carboxylate 
group of the docked MVA was positioned in line with the 
guanidinium group of Arg241 establishing an ionic interaction with 
the substrate. Interestingly, with time evolution of the MD 
simulation, Arg241 moved gradually towards the highly negatively 
charged triphosphate tail of ATP, forming an ionic interaction with 
the α- and γ-phosphate of ATP (Figure S11), whereas the carboxylate 
group of MVA forms hydrogen bond interaction with Ser201 (Figure 
2). Thus Arg241 plays a predominant role in organizing the nucleotide 
for an in-line phosphate transfer. 
3.1.5 Effect of mutation of the key residues in MVK
In order to validate the role of the key residues in the active site of 
MVK identified from MD simulations, these residues were mutated 
using the mutation feature in Accelrys Discovery studio and the 
resulted mutants were subjected to MD simulations. 
In the wild-type enzyme (Figure 2b), Lys13 forms an ionic interaction 
with Asp204. MD simulations of the K13A mutant (Figure 3a) reveal 
that lack of this interaction in the mutant abolished the hydrogen 
bond interaction between Ser201 and the carboxylate group of the 
substrate. As a result, mevalonate adopts a significantly different 
‘bent’ conformation, with its carboxylate group of mevalonate 
forming an ionic interaction with Arg251. Interestingly, a notable 
conformational change of the loop proceeding the α8 helix is 
observed causing the displacement of the α8 helix, as a result, the 
catalytic residue Arg241 moves away from the catalytic centre 
whereas Lys244 move in the proximity of the β-, γ- phosphate of ATP, 
nested in a similar location to where Arg241 is in the WT kinase. Thus 
this loop may play an auxiliary role in orientating the catalytic Arg241 
around the ATP phosphate tail so as to facilitate the phosphate 
transfer.
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Fig 3. MD simulated structures of MVK mutants (a) K13A, (b) 
S146A, (c) S201A, (d) D204A, (e) R241A.
Previous kinetic study showed a S146A mutation resulted in 
significantly reduced kcat38. Our MD simulations showed that 
mutating of Ser146 on the glycine-rich loop into alanine causes 
conformational change around the loop connecting the α6 and α7 
helix, and therefore the hydrogen bond interaction between the 
carboxylate group of mevalonate and Ser201 is abolished (Figure 3b). 
The loss of the interaction between the substrate mevalonate and 
S201 mutation due to the S146A mutation may account for the 
largely reduced activity observed in the previous kinetic study 38. It 
also indicates that Ser146 on the glycine-rich loop is critical in 
maintaining the loop connecting the α6 and α7 helix to hold the 
mevalonate substrate in the catalytic site, so as to facilitate the 
catalysis of the phosphorylation.
MD simulations of S201A caused the loop linking the α6 and α7 helix 
to undergo a remarkable conformational shift such that the 
hydrogen bond formed between His197 on this loop and Glu193 is 
lost, and His197 forms a H-bond with the carboxylate of mevalonate 
instead. The loss of the interaction between the subtract carboxylate 
and Ser201 due to the S201A mutation is compensated by an ionic 
interaction with Arg251 (Figure 3c). Thus, compared to the WT 
kinase, the mutant displays a less organized catalytic site analogous 
to the configuration of MVK in absence of the substrate (Figure 2a). 
In D204A, the coordination between Mg2+ and of the aspartate is lost 
due to lack of the carboxylate side chain, such that the magnesium 
ion adopts an alternative position at an opposite plane of the ATP 
triphosphoryl tail and the coordination with the β- and γ- phosphates 
of ATP is established. The movement of the metal ion caused 
significant displacement of mevalonate, resulting in an unfavourable 
orientation for phosphate transfer to occur (Figure 3d). Furthermore, 
the loop connecting the α6 and α7 helix also undergoes notable 
change such that the interaction between mevalonate and Ser201 is 
abolished and also replaced by the ionic interaction with Arg251. 
MD simulations disclosed the R241A mutation induced 
conformational change of the loop proceeding the α8 helix and the 
displacement of the α8 helix so that Lys244 to move toward the 
active site and nest at an almost identical position to Arg241 in the 
wild-type MVK, helping to hold the triphosphoryl moiety of ATP in 
the catalytic site (Figure 3e). Significant conformational change is 
also observed at the loop connecting the α6 and α7 helix such that 
the interaction between the carboxylate group of the mevalonate 
and Ser201 is lost. As a result, the substrate adopts a catalytically 
unfavourable orientation in relation to ATP.
In summary, MD simulations of the MVK variants validated the role 
of the key residues in the catalytic reaction; The loop connecting α6 
and α7 helix is crucial in positioning mevalonate substrate in 
favourable orientation in relation to ATP, and the loop proceeding 
the α8 helix plays an auxiliary role in orientating the Arg251 toward 
the phosphate tail of ATP, facilitating the phoshorylation reaction to 
happen. 
3.2 Conformational change during substrate binding 
Molecular dynamics simulations were conducted for ATP-Mg2+-MVK 
to elucidate the conformational changes in MVK induced by 
substrate binding. In the absence of the substrate mevalonate, a 
concave opening in the surface of the protein created an entrance to 
the active site of ATP-Mg2+-MVK, forming an ‘open’ conformation 
(Figure 4a). In contrast, while the substrate mevalonate is bound, this 
concave opening is pinched together forming a narrow active site 
such that the substrate is locked into this catalytically active state in 
the ‘closed’ conformation (Figure 4b). 
The significant conformational change of the active site is mainly 
mediated by the loop connecting the α6 and α7 helix. In absence of 
the substrate, Ser201 forms an interaction with Asp204 (Figure 4c). 
In the substrate bound complex, Ser201 on the loop forms a 
hydrogen bond interaction with the carboxylate group of 
mevalonate, which results in a remarkable conformational change in 
the loop (Figure 4d). In addition, in the ATP-Mg2+-MVK structure, 
His197 is hydrogen-bonded with ATP (Figure 4c), whereas in 
presence of the substrate, His197 undergoes a notable change, 
forming hydrogen bond interactions with Glu193 and the water 
molecules coordinated to the metal ion. 
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Fig. 4 Open and Closed conformation of MVK during substrate 
binding. (a) Surface representation of MD simulated ATP-Mg2+-
MVK complex, involved residues coloured in orange; (b) Surface 
representation of MD simulated ATP-Mg2+-MVK–MVA complex, 
involved residues coloured in orange; (c) Secondary Structure of 
MD simulated ATP-Mg2+-MVK complex with loop coloured 
yellow; (d) Secondary Structure of MD simulated ATP-Mg2+-
MVK-MVA complex with loop coloured red.
S. pneumoniae MVK was reported to be able to catalyze the 
phosphorylation of mevalonate diphosphate, the substrate of its 
GHMP fellow mevalonate pathway enzyme, mevalonate 
diphosphate decarboxylase (MDD) 41. Thus the binding mode of 
mevalonate in MVK elucidated here would provide crucial 
information on the tailoring of the enzyme to expand substrate scope 
to exploit its broader biotechnological applications.
3.3 Phosphorylation mechanism of MVK
Mutation of Asp204 in human MVK resulted in a >40,000-fold 
diminution in the catalytic rate constant, kcat. Thus, it was 
hypothesized that this aspartate residue may function as a catalytic 
base to deprotonate the C5-OH of mevalonate, which then 
undergoes a nucleophilic attack on the γ-phosphate of ATP 18,24. 
However, the detection of activity, albeit substantially reduced 
compared to the wild-type enzyme, indicates either that Asp204 
does not have a catalytic role or that an alternative catalytic pathway 
is possible. 
Recently, QM/MM studies on GHMP kinases galactokinase (GALK) 22 
and phosphomevalonate kinase (PMK) 23 revealed that these 
enzymes actually function through a direct phosphorylation 
mechanism. Thus it is necessary to resolve the uncertainty around 
the mechanism of MVK, a representative GHMP kinase that was 
conventionally deems to catalyse the phosphorylation via the 
catalytic base mechanism.
Cluster analysis was conducted to obtain the representative 
structures from the MD simulated trajectory of the ATP -Mg2+-MVK-
MVA complex. Two key interatomic distances were monitored to 
choose a suitable structure for QM/MM. i.e. the distance between 
the γ-phosphate of ATP and the C5-hydroxyl oxygen of mevalonate 
and the distance between Asp204 and the C5-hydroxyl hydrogen of 
mevalonate (Table S4). From the ten representative structures of the 
last 10 ns of the MD trajectory (Figure S12), it was evident that no 
interatomic interaction exists between the aspartate residue and the 
C5-OH hydrogen; Moreover, the proton on the hydroxyl group points 
away from Asp204 in all representative structures, thus it is unlikely 
that the phosphorylation would occur via a catalytic base mechanism 
involving Asp204.
Here QM/MM studies were conducted to elucidate the mechanism 
of phosphorylation reaction catalyzed by MVK. The QM region was 
composed of the side chains of key residues Lys13, Ser146, Asp204 
and Arg241, the Mg2+ ion, the three water molecules coordinated to 
magnesium, mevalonate and the triphosphoryl tail of ATP. In total 45 
heavy atoms were included. In addition, four structural water 
molecules identified from MD simulations were included in the QM 
region, two of which formed hydrogen bonds with the transferring γ-
phosphate of ATP and another located at the β-phosphate of ATP. 
Strikingly, in the QM/MM optimized geometry, the hydroxyl group of 
the substrate approached the γ-phosphate of ATP (the distance 
between the γ-phosphate of ATP and the C5-OH group of mevalonate 
was 3.26 Å), in the meantime, the coordinate bond between the 
metal ion and the hydroxyl oxygen of mevalonate was broken. As a 
result, a fourth water molecule approached the active site to 
coordinate with Mg2+, replacing the coordination with the substrate 
observed in the MD simulated structure such that the favoured 
octahedral geometry of the metal ion was maintained. 
In the optimized stationary points corresponding to the reactant, TS 
and product, Arg241 forms an ionic interaction with the α-, β- and γ-
phosphate groups of ATP. Furthermore, Arg241 forms an important 
ionic interaction with the β-,γ-bridging oxygen of ATP, thus the 
negative charge that accumulates at the β,γ-bridging oxygen during 
bond cleavage in the phosphate transfer process is balanced (Figure 
6). 
The calculated reaction barrier is 17.1 kcal/mol (Figure 5), which is in 
close agreement with the experimental barrier of 15.8 kcal/mol 18. 
The transition state was validated by a unique imaginary frequency 
of -166.3 cm-1, which corresponds to the vibration of the phosphate 
transfer. From the QM/MM study we find that MVK follows a direct 
phosphorylation mechanism, despite the presence of Asp204 in the 
active site, which was conventionally proposed to be a catalytic base 
in previous literature18. 
Pauling’s formula42 D(n) = D(l) – 0.6 log n was used to quantify the 
associative or dissociative nature of the TS. In the formula the term 
D(l) is the average length of a P-O bond valued at 1.73 and D(n) is the 
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average of r O-Pγ and r Pγ-Oβ3 in the transition state. In the optimized 
transition state of MVK r O-Pγ was 1.86 Å and r Pγ-Oβ3 was 1.83 Å. The 
estimated fractional bond number (n) is 0.61, representing 39% 
dissociative character. This is in conjunction with other GHMP 
kinases such as GALK22 and PMK 23, which were found to also follow 
a direct phosphorylation mechanism with a dissociative nature, as 
well as Isopentenyl phosphate kinase (IPK) in the mevalonate 
pathway that belongs to a distinct kinase family, amino acid kinase 
(AAK) family43.
Fig. 5 Reaction profile of mevalonate kinase obtained by 
QM/MM calculations. The red line is the energy profile 
calculated using B97D/6-31g(d) method, and the dashed back 
line is the corrected energy profile using same DFT functional 
and 6-311++g(d,p) basis set.
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Fig. 6 2D sketch of the reactant, TS and the product in the 
phosphorylation of mevalonate catalysed by MVK. The reaction 
follows a phosphorylation mechanism, i.e. the proton of the 
substrate hydroxyl group is abstracted by the γ-phosphate 
oxygen of ATP while the hydroxyl oxygen of the substrate undergoes 
nucleophilic attack on the γ-phosphate phosphore of ATP. 
Conclusions
MVK is a key enzyme in the biosynthesis of IPP, the precursor for 
isoprenoids. The lack of a complete kinase structure containing the 
substrate mevalonate and uncertainty of the Mg2+ location has 
limited the understanding of the catalytic mechanism of the kinase 
and therefore its biotechnological applications of MVK. Here we 
determined a catalytically competent structure of MVK-ATP-Mg2+-
MVA based molecular docking, MD simulations and QM/MM studies. 
Our results show that Glu193 is not directly coordinated to Mg2+, 
instead, it forms hydrogen bond interactions with the coordinating 
water molecules. Strikingly, Asp204 which was previously implicated 
as a catalytic base, forms a coordinate bond with Mg2+. Furthermore, 
we found that Ser146 on the glycine-rich loop is actually involved in 
hydrogen bond interactions with the highly mobile triphosphoryl tail 
of ATP, instead of being coordinated to Mg2+, as hypothesized 
previously. Notably, our MD simulations revealed that Arg241 moves 
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into the active site to form salt bridge interactions with the α- and γ-
phosphate of ATP, indicating it is pivotal in organizing the highly 
flexible nucleotide tail for in-line phosphate transfer, and 
neutralising the negative charge developed during phosphate 
transfer. This ordering of the triphosphate tail would result in a 
decrease in the entropy of the system which is, most likely, balanced 
by favourable enthalpy changes resulting from the non-covalent 
interactions between the enzymes and its substrates.
We also investigated the conformational change induced by 
substrate binding in MVK was by MD simulations. We found that in 
the absence of the substrate, there is an opening at the surface of 
MVK for the entry of a substrate molecule, which is mediated by the 
hydrogen bond interaction between Ser201 and Asp204; In the 
presence of the substrate, significant conformational change was 
observed in the loop connecting the α6 and α7 helix and closed 
conformation is observed as a result of Ser201 forming a hydrogen 
bond with the carboxylate group of the substrate. It is possible that 
similar conformational changes occur in other GHMP kinases which 
share a similar overall structure with active sites nested in the cleft 
between the two main motifs. 
Furthermore, our QM/MM studies reveal that MVK follows a direct 
phosphorylation reaction mechanism. This argues the conventionally 
postulated catalytic base mechanism. Arg241 plays a pivotal role in 
organizing the highly flexible triphosphate tail of ATP, as well as 
neutralizing the negative charge accumulated at the β-,γ-bridging 
oxygen of ATP during phosphate transfer. Thus far, MVK, GALK 22 and 
PMK 23 have all been shown through QM/MM studies to have an in-
line, direct phosphate transfer mechanism instead of a catalytic base 
mechanism. Homoserine kinase, which lacks such potential catalytic 
base residue in the active site would also function through direct 
phosphorylation. Taken together, we suggest that direct 
phosphorylation may be the predominant mechanism in most GHMP 
kinases. Such a conclusion challenges the generally held view that the 
majority of these enzymes function via the catalytic base mechanism. 
The results presented here would provide the basis for the rational 
design and engineering of MVK, a key enzyme in the mevalonate 
pathway for biosynthesis of isoprenoid-based biofuels. It may also 
provide valuable insights for development of potential 
pharmacological chaperone therapies for the stabilisation of the 
variant proteins in MKD-related diseases.
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